Conference Coverage

Oxybutynin nets dramatic reduction in hot flashes

SAN ANTONIO – The 6-week reduction in a hot flash score capturing both frequency and severity was about 30% with placebo, 65% with oxybutynin 2.5...

Conference Coverage

CTC matches MD judgment for mBC therapeutic choice

SAN ANTONIO – For patients with ER-positive, HER2-negative metastatic breast cancer, the use of CTC counts can help clinicians decide between...

Conference Coverage

Nothing to gain from chemo after pCR achieved

SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from...